eCommons@AKU
Department of Radiation Oncology

Medical College, Pakistan

6-2020

Tumor boards during COVID-19 pandemic
Ahmed Nadeem Abbasi

Follow this and additional works at: https://ecommons.aku.edu/pakistan_fhs_mc_radiat_oncol
Part of the Oncology Commons, Radiology Commons, and the Virus Diseases Commons

EDITORIAL

Tumor Boards during COVID-19 Pandemic
Ahmed Nadeem Abbasi
Department of Oncology, The Aga Khan University, Karachi, Pakistan

’

COVID-19 pandemic is a global healthcare issue. Cancer patients
management also got eﬀected due to the emergency measures
adopted by the healthcare policy-makers in order to provide
urgent services to COVID-19 patients. In the recent few weeks,
some guidelines and directives are being published and circulated, which are being followed by cancer-care providers.1,2
Globally, the eﬀects of this COVID-19 pandemic were felt by both
healthcare providers and healthcare policy-makers. This unprecedented pandemic is being faced across the world in all countries;
hence, every country came up with national plans of service provision that addressed not only the COVID-19 patients' care, but also
deﬁne guidelines for the treatment of cancer patients during this
diﬃcult period.3 The ultimate beneﬁciary of modern well-networked cancer-care systems is the patient. Cancer patients’ care
and management is also being considered as a serious task by
healthcare policy-makers. As a ﬁrst step in cancer management, a
site-speciﬁc multi-disciplinary tumor board is conducted. When it
comes to cancer patients’ treatment, recommendations made at
site-speciﬁc multidisciplinary tumor boards form the basis of a
comprehensive plan of management.4
During this pandemic, it is not practically possible to gather
colleagues in a conference room for multi-disciplinary tumor
board, due to the restrictions as per directives aiming towards the
control of this pandemic. These board meetings are open to all
colleagues who are providing cancer-care in other hospitals as
well. Instead of cancelling these tumor boards, site-speciﬁc teams
have decided to take the help of information technology expert
colleagues and to conduct on-line web-based meetings in which
clinicians discuss their cases in the same way as they were doing
before the pandemic. The quality of cross-deliberations was found
to be similar during these on-line meetings. The concept of multi
disciplinary interaction remained intact and concerned doctors
were able to involve all relevant specialty doctors. Active participation of junior trainee postgraduate residents and under-graduate
students was also observed. The objective of sharing this experience was to encourage the colleagues, across the world to
consider making this arrangement for their respective site-speciﬁc tumor boards.
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This is a useful take-home message for the specialist
colleagues, who are working in the developing countries. As far
as our provision of cancer-care processes are concerned, we
strongly recommend the establishment of high quality sitespeciﬁc tumor boards in every institution where cancer
patients are being treated. We consider these tumor boards as
5
a lifeline of cancer patients in developing countries.
An International Collaborative Group has published a recommended practical approach pertaining to our day-to-day clinical services, which we are providing to our cancer patients in
this very diﬃcult time of history when the whole world is facing
a serious pandemic.6 We are fully aware of the fact that site-speciﬁc multidisciplinary tumor board plays a pivotal role in the
overall comprehensive cancer-care plan.
We have to discuss our cases before oﬀering the ﬁrst modality
of treatment to patients. This is the only way we can ascertain
that best management plan is being recommended to these
patients. It is advisable to conduct these tumor board meetings with an open access to both junior and senior doctors of all
concerned specialties.
Innovative measures are required for the continuation of all
quality practices, processes and procedures during the time of
this COVID-19 pandemic, which is a global problem. If we will
not be able to conduct our tumor boards during this time of
pandemic then eventually the outcome of patients will not be
the same as before. Large conference rooms are being used for
these meetings. These site-speciﬁc boards are an important
integral part of students' clinical rotations. In certain circumstances, these multidisciplinary tumor boards can be
conducted via web link as we are doing in case of pediatric
neuro-oncology tumor board, which is being conducted once a
month. This is a video-linked meeting in which few centres of
Pakistan get connected with the Sick Kids Hospital, Toronto,
Canada for the discussion of Pakistani cancer children cases.
During the time of COVID-19 pandemic, the same strategy was
followed and now we are conducting majority of our tumor
boards via networking softwares, which can be operated on
personal mobile phones and home computers as well. In this
way, all stakeholders can give their expert input pertaining to
their speciﬁc specialty. Tumor board discussions have to be
continued in the same manner until this pandemic is over; and
then we can come back to our conventional way of sitting
together in a room for discussion, debate and deliberation on
each case presented at the tumor board meeting.
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